← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Echelon Biosciences, Inc.
Salt Lake City, UT
$11,679,651
Total funding
34
Grants
Funding over time
peak $1.3M · FY2008–24$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,878,946 · 30
FDA$1,025,464 · 2
NSF$775,241 · 2
By mechanism
R43$4,247,271 · 22
R44$3,218,073 · 4
N44$1,723,618 · 2
R42$1,316,155 · 3
—$775,241 · 2
R41$399,293 · 1
Investigators at Echelon Biosciences, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
IGF::OT::IGF -- Biomarkers for Alcohol and ALD$625,360
N44 · FY2014 · AA
SBIR Phase II: Near Infrared Substrates for Imaging Autotaxin Activity In Vivo$625,241
· FY2011 · TIP
Biomarkers for Alcohol and Alcoholic Liver Disease$548,090
N44 · FY2012 · AA
Biomarkers for Alcohol and Alcoholic Liver Disease$520,907
N44 · FY2013 · HD
CELL PERMEANT PHOSPHOINOSITIDES$496,798
R44 · FY2001 · GM
New Approach to Phospholipidosis Prediction$449,426
R44 · FY2014 · FD
CELL PERMEANT PHOSPHOINOSITIDES$443,527
R44 · FY2002 · GM
New Approach to Phospholipidosis Prediction$426,154
R44 · FY2015 · FD
Innovative Point-of-Care Solutions for Long-term Alcohol Biomarkers$399,293
R41 · FY2024 · AA
Liposome Overlays For Protein-Ligand Selectivity$374,695
R44 · FY2003 · GM
Phosphoinositide 3-Kinase Assays in Cancer Diagnosis$366,016
R44 · FY2002 · CA
Phosphoinositide 3-Kinase Assays in Cancer Diagnosis$351,246
R44 · FY2003 · CA
Liposome Overlays For Protein-Ligand Selectivity$310,211
R44 · FY2004 · GM
Methylerythritol Phosphate Pathway-Specific Natural Products as Antibacterials$300,000
R43 · FY2009 · AI
Methylerythritol Phosphate Pathway Inhibitors Targeting Gram-Negative Infections$300,000
R43 · FY2008 · AI
Methylerythritol Phosphate Pathway Inhibitors Targeting Gram-Negative Infections$299,834
R43 · FY2009 · AI
Methylerythritol Phosphate Pathway-Specific Natural Products as Antibacterials$292,461
R43 · FY2008 · AI
Aptamer-based Glycomics Tools$277,549
R42 · FY2010 · GM
Aptamer-based Glycomics Tools$277,549
R42 · FY2009 · GM
ISOPRENOID COMPOUNDS FOR BIOLOGICAL STUDIES$266,879
R42 · FY2000 · DK